Related Experiment Video
Updated: Jul 26, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers
Pouriya Sameti1, Mohammad Amini2, Fatemeh Oroojalian3,4
1Department of Biology, Higher Education Institute of Rab-Rashid, Tabriz, Iran.
Abstract:
MicroRNAs (miRNAs) are small single-stranded regulatory RNAs that are shown to be dysregulated in a wide array of human cancers. MiRNAs play critical roles in cancer progression and function as either oncogenes or tumor suppressors through modulating various target genes. Therefore, they possess great potential as diagnostic and therapeutic targets for cancer detection and treatment. In particular, recent studies have illustrated that miR-425 is also dysregulated in various human malignancies and plays a fundamental role in cancer initiation and progression. miR-425 has been reported to function as a dual-role miRNA participating in the regulation of cellular processes, including metastasis, invasion, and cell proliferation by modulating multiple signaling pathways, such as TGF-β, Wnt, and P13K/AKT pathways. Therefore, regarding recent researches showing the high therapeutic potential of miR-425, in this review, we have noted the impact of its dysregulation on signaling pathways and various aspects of tumorigenesis in a variety of human cancers.
Insights
MicroRNAs (miRNAs) are key regulators in cancer. This review highlights miR-425
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small regulatory RNAs implicated in various human cancers.
- Dysregulated miRNAs can act as oncogenes or tumor suppressors, influencing cancer progression.
- miRNAs hold promise as diagnostic and therapeutic targets for cancer management.
Purpose of the Study:
- To review the role of miR-425 in human malignancies.
- To explore the impact of miR-425 dysregulation on cancer initiation and progression.
- To analyze miR-425's modulation of key signaling pathways in tumorigenesis.
Main Methods:
- Literature review of recent studies on miR-425 and cancer.
- Analysis of miR-425's regulatory functions in cellular processes.
- Examination of miR-425's involvement in TGF-β, Wnt, and P13K/AKT signaling pathways.
Main Results:
- miR-425 is dysregulated in multiple human cancers.
- miR-425 exhibits dual roles, affecting metastasis, invasion, and proliferation.
- miR-425 modulates critical cancer-related signaling pathways.
Conclusions:
- miR-425 is a significant factor in tumorigenesis across various cancers.
- Understanding miR-425's dysregulation offers potential for novel cancer diagnostics and therapeutics.
- Targeting miR-425 presents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The Nucleolus

